Document is current
Any future updates will be listed below
-
Authors
Tana, Claudio
Raffaelli, Bianca
Souza, Marcio Nattan Portes
de la Torre, Elena Ruiz
Massi, Daniel Gams
Kisani, Najib
García-Azorín, David
Waliszewska-Prosół, Marta
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 3 January 2024
First Online: 29 January 2024
Declarations
:
: Not applicable.
: CT, BR, DGA, MWP are editorial board members of the Journal of Headache and Pain. BR reports personal fees from AbbVie, Eli Lilly, Lundbeck, Novartis and Teva for participating in advisory boards and/or speaker activities as well as research funding from Novartis. MNPS reports personal fees from AbbVie, Eli Lilly, Lundbeck, Pfizer, LIBBS and Teva for participating in advisory boards and/or speaker activities. DGA has received research funding from the Regional Health Administration (Gerencia Regional de Salud SACYL) in Castilla y Leon, Spain. Speaker/travel grants/ clinical trials from Teva, Abbvie, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Biohaven. MWP reports personal fees from AbbVie, Pfizer and Teva for speaker activities.
